• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Irhythm Technologies Inc (NQ: IRTC )

    73.99 +0.09 (+0.12%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 420,162
    Open 73.78
    Bid (Size) 73.62 (1)
    Ask (Size) 89.83 (2)
    Prev. Close 73.90
    Today's Range 71.00 - 75.29
    52wk Range 55.92 - 124.11
    Shares Outstanding 29,403,360
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    iRhythm Technologies to Participate in the Citi 2024 Global Healthcare Conference
    From iRhythm
    Via GlobeNewswire
    iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
    Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economic... 
    From iRhythm
    Via GlobeNewswire

    Performance

    YTD
    -26.99%
    -26.99%
    1 Month
    -0.50%
    -0.50%
    3 Month
    +5.68%
    +5.68%
    6 Month
    -16.81%
    -16.81%
    1 Year
    -14.71%
    -14.71%

    More News

    Read More
    iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
    From iRhythm
    Via GlobeNewswire
    Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
    Via Benzinga
    Earnings Preview For iRhythm Technologies
    Via Benzinga
    IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
    From iRhythm
    Via GlobeNewswire
    iRhythm Technologies Announces Third Quarter 2024 Financial Results
    From iRhythm
    Via GlobeNewswire
    Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock
    Via Benzinga
    Key Takeaways From iRhythm Technologies Analyst Ratings
    Via Benzinga
    Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
    From iRhythm
    Via GlobeNewswire
    Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
    Via Benzinga
    Topics Government
    Exposures Political
    IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results
    Via Benzinga
    With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
    Via Benzinga
    Exposures Product Safety
    Crude Oil Rises Sharply; 3M Posts Upbeat Earnings
    Via Benzinga
    Exposures Fossil Fuels
    Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
    From iRhythm
    Via GlobeNewswire
    iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
    From iRhythm
    Via GlobeNewswire
    IRHYTHM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of iRhythm Technologies, Inc. - IRTC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
    From iRhythm
    Via GlobeNewswire
    iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
    From iRhythm
    Via GlobeNewswire
    iRhythm Technologies Enters License Agreement with BioIntelliSense for Multiparameter Sensor Technology to be Used in Ambulatory Cardiac Monitoring
    From iRhythm
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.